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Abstract
The time-course of the pathological effects induced by the venom of the snake Bothrops
asper in muscle tissue was investigated by a combination of histology, proteomic analysis
of exudates collected in the vicinity of damaged muscle, and immunodetection of extracellu-
lar matrix proteins in exudates. Proteomic assay of exudates has become an excellent new
methodological tool to detect key biomarkers of tissue alterations for a more integrative per-
spective of snake venom-induced pathology. The time-course analysis of the intracellular
proteins showed an early presence of cytosolic and mitochondrial proteins in exudates,
while cytoskeletal proteins increased later on. This underscores the rapid cytotoxic effect of
venom, especially in muscle fibers, due to the action of myotoxic phospholipases A2, fol-
lowed by the action of proteinases in the cytoskeleton of damaged muscle fibers. Similarly,
the early presence of basement membrane (BM) and other extracellular matrix (ECM) pro-
teins in exudates reflects the rapid microvascular damage and hemorrhage induced by
snake venommetalloproteinases. The presence of fragments of type IV collagen and perle-
can one hour after envenoming suggests that hydrolysis of these mechanically/structurally-
relevant BM components plays a key role in the genesis of hemorrhage. On the other hand,
the increment of some ECM proteins in the exudate at later time intervals is likely a conse-
quence of the action of endogenous matrix metalloproteinases (MMPs) or of de novo syn-
thesis of ECM proteins during tissue remodeling as part of the inflammatory reaction. Our
results offer relevant insights for a more integrative and systematic understanding of the
time-course dynamics of muscle tissue damage induced by B. asper venom and possibly
other viperid venoms.
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Author Summary
The local pathology induced by viperid snakes is characterized by a complex of alterations
as consequence of direct and indirect effects of the toxins present in the venom, as well as
the host response to tissue damage, and constitutes a dynamic process of degenerative and
reparative events. The pathogenesis of local effects induced by Bothrops asper venom has
been studied by traditional methodologies. Recently, proteomic analysis of wound exu-
dates collected in the vicinity of affected tissue has become a powerful tool to study the
pathogenesis of local envenoming from a more integrative perspective. Thus, in the pres-
ent study we analyzed the dynamics of the local effects induced by B. asper venom in the
gastrocnemius muscle of mice through a proteomic and immunochemistry approach in
order to identify biomarkers of tissue damage and repair during the course of envenoming.
Our results showed an early presence of cytosolic and mitochondrial proteins in exudates
as compared to cytoskeletal proteins, which reflect the rapid cytotoxic effect of venom, fol-
lowed by the action of endogenous proteinases in the cytoskeleton of damaged muscle
fibers later on in the course of envenoming. On the other hand, the early presence of extra-
cellular matrix components and the increment of some of them in exudates, reflect the
rapid microvascular damage and hemorrhage induced by the venom, followed by the
action of endogenous matrix metalloproteinases (MMPs) during tissue remodeling as part
of the inflammatory response. Overall our study allowed the identification of key biomark-
ers of tissue damage and repair as part of the pathological effects induced by B. asper
venom in skeletal muscle, which offer relevant insights for a better understanding of the
complex dynamics of local pathology induced by viperid snakebite envenoming.
Introduction
The viperid snake Bothrops asper is responsible for most snakebite cases in Central America
and some regions of Mexico and South America [1,2]. The local pathology induced by viperid
snakes is characterized by edema, blistering, hemorrhage, lymphatic vessel damage, and necro-
sis of skin and muscle, some of which can be attributed to the degradation of extracellular
matrix (ECM) [1,3]. Such alterations develop very rapidly after the bite, and in some cases can
lead to permanent tissue damage, regardless of the application of antivenom treatment. Signifi-
cant efforts have been undertaken over the last several decades to identify the toxins responsi-
ble for these effects, as well as to characterize the pathogenesis of these alterations [3–5].
Nevertheless, the complexity of this pathology demands further analyses into hitherto
unknown aspects of tissue damage and the complex interplay between degenerative and early
reparative events. As envenoming is a dynamic event, it is critical to investigate the process
over time, which is the main focus of this study.
The pathogenesis of local effects induced by B. asper venom has been studied by traditional
methodologies, such as histological and ultrastructural analyses, immunohistochemical meth-
ods, and quantification of particular components and tissue markers in tissue homogenates or
fluids, as a consequence of the action of crude venom and purified toxins [3,6–12]. Despite sig-
nificant advances in the study of local tissue damage with these approaches, subtle changes in
key biomarkers of tissue damage and repair during the course of envenoming remain to be
identified and characterized. Moreover, since the venom is a highly complex mixture of com-
ponents functioning over time, relevant information related to synergistic action of toxins
could be missed when working only with isolated toxins; therefore, studies with crude venom
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may better advance our understanding from a predominantly reductionist to a holistic view of
these multifactorial time-dependent phenomena.
Recently, proteomic analysis of exudates collected around the affected tissue has become a
new methodological tool to study the pathogenesis of local tissue damage induced by snake
venom from a more integrative perspective [13–17]. This approach has been used to study the
alterations caused by B. asper snake venom [15], and some of its toxins, such as a myotoxic
phospholipase A2 (PLA2) and a hemorrhagic snake venom metalloproteinase (SVMP)
[13,14,16]. Moreover, proteomic analysis has allowed the comparison between the action of
different types of hemorrhagic and non-hemorrhagic SVMPs [13,16,17]. These studies have
identified differences in the species and abundance of intracellular proteins, ECM components,
and other proteins present in exudates, which offer new insights in the mechanism of action of
these toxins, and in the tissue damage induced by the venom [13–16]. However, these studies
have been carried only at early time periods in the course of envenoming and therefore provide
only a narrow window within the whole scenario of local pathology.
In the present study we analyzed the time-course variation in the protein composition and
abundance of wound exudates collected from mouse gastrocnemius muscle injected with B.
asper snake venom utilizing a proteomic and immunochemistry approach, in conjunction with
histological analysis of tissue alterations, with the aim of identifying biomarkers of tissue dam-
age and tissue remodeling characteristic of early and late stages of envenoming. This approach
allowed the identification of key differences in some intracellular proteins and ECM compo-
nents over time, which underscores the rapid cytotoxic and hemorrhagic effect of venom, fol-
lowed by the action of endogenous proteinases associated with tissue remodeling later on in
the course of envenoming. These results offer relevant insights for a better understanding of
the complex pathological phenomena of viperid snakebite envenoming.
Methods
Venom
B. asper venom was obtained from more than 40 adult specimens collected in the Pacific region
of Costa Rica and maintained at the serpentarium of Instituto Clodomiro Picado. After collec-
tion, venoms were pooled, lyophilized, and stored at -20°C until used.
Ethics statement
CD-1 mice with a body weight between 18 and 20 g were used for the in vivo studies. All the
experimental protocols involving the use of animals were approved by the Institutional Com-
mittee for the Care and Use of Laboratory Animals (CICUA) of the University of Costa Rica
(protocol approval number CICUA 025–15), and meet the International Guiding Principles
for Biomedical Research Involving Animals (CIOMS).
Histology
Groups of four CD-1 mice (18–20 g) were injected in the right gastrocnemius with 50 μg of B.
asper venom, dissolved in 50 μL of 0.12 M NaCl, 0.04 M phosphate, pH 7.2 solution (PBS).
Control mice were injected with PBS alone. After 1, 6 and 24 h of injection, mice were sacri-
ficed by CO2 inhalation and samples of the injected muscles were resected and added to 10%
formalin solution in PBS. After 48 h fixation, routine processing of tissues was performed, fol-
lowed by embedding in paraffin. Sections of 5 μm thickness were obtained for each sample and
stained with hematoxylin–eosin for light microscopic observation.
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Collection of wound exudates
Groups of five CD-1 mice (18–20 g) were injected in the right gastrocnemius with 50 μg of B.
asper venom, dissolved in 50 μL of PBS. After 1, 6 and 24 h of injection, mice were sacrificed by
CO2 inhalation, a 5 mm incision was made with a scalpel in the skin overlying the injected
muscle, and a heparinized capillary tube was introduced under the skin to collect the wound
exudate fluid. An approximate volume of 20–50 μL of exudate was collected from each mouse.
Exudate samples were then pooled and lyophilized for further analysis.
Quantification of creatine kinase (CK) activity in wound exudates
Wound exudates were collected as previously described and centrifuged at 5000 g for 3 min.
The CK activity of supernatants was determined using a commercial kit (CK-Nac, Biocon
Diagnostik, Germany). CK activity was expressed in International Units /L (IU/L).
Proteomic analysis of wound exudates
Lyophilized wound exudate samples were resuspended in water and protein quantification was
performed using micro BCA protein assay kit (Thermo Scientific). Twenty micrograms of pro-
tein was precipitated with acetone, resuspended in Laemmli buffer and separated in a 5–20% pre-
cast electrophoresis gel (Bio-Rad). The gel was stained with Coomassie Brilliant Blue and lanes
were cut into 8 equal size slices. Gel slices were destained for 3 h and the proteins were reduced
(10 mM dithiothreitol, DTT) and alkylated (50 mM iodoacetamide) at room temperature. Gel
slices were then washed with 100 mM ammonium bicarbonate, dehydrated with acetonitrile and
dried in a speed vac, followed by in-gel digestion with a solution of Promega modified trypsin
(20 ng/μL) in 50 mM ammonium bicarbonate for 30 min on ice. Excess trypsin solution was
removed and the digestion continued for 18 h at 37°C. The resulting tryptic peptides were
extracted from gel slices with two 30 μL aliquots of a 50% acetonitrile/5% formic acid solution.
These extracts were combined and dried to 15 μL for mass spectrometric (MS) analysis.
LC/MS/MS was performed using a Thermo Electron Orbitrap Velos ETDmass spectrometer
system. Analytical columns were fabricated in-house by packing 0.5 cm of irregular C18 Beads
(YMC Gel ODS-A, 12 nm, I-10-25 um) followed by 7.5 cm Jupiter 10 μmC18 packing material
(Phenomenex, Torrance, CA) into 360 x 75 μm fused silica (Polymicro Technologies, Phoenix,
AZ) behind a bottleneck. Samples were loaded directly onto these columns for the C18 analyti-
cal runs. 7 μL of the extract was injected, and the peptides were eluted from the column at
0.5 μL/min using an acetonitrile/0.1M acetic acid gradient (2–90% acetonitrile over 1 h). The
instrument was set to Full MS (m/z 300–1600) resolution of 60,000 and programmed to acquire
a cycle of one mass spectrum followed by collision-induced dissociation (CID) MS/MS per-
formed in the ion trap on the twenty most abundant ions in a data-dependent mode. Dynamic
exclusion was enabled with an exclusion list of 400 masses, duration of 60 seconds, and repeat
count of 1. The electrospray voltage was set to 2.4 kV, and the capillary temperature was 265°C.
The data were analyzed by database searching using the Sequest search algorithm in Prote-
ome Discoverer 1.4.1 against the Uniprot Mouse database from July 2014. Spectra generated
were searched using carbamidomethylation on cysteine as a fixed modification, oxidation of
methionine as a variable modification, 10 ppm parent tolerance and 1 Da fragment tolerance.
All hits were required to be fully tryptic. The results were exported to Scaffold (version 4.3.2,
Proteome Software Inc., Portland, OR) to validate MS/MS based peptide and protein identifica-
tions, and to visualize multiple datasets in a comprehensive manner. Confidence of protein
identification in Scaffold is shown as 95% confidence (green coloration) and 80% to 94%
confidence (yellow coloration). Relative quantization of proteins was performed by summing
all data from the 8 gel slices for a particular sample in Scaffold and then displaying the
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Quantitative Value from the program. This number gives an average total of non-grouped
spectral counts for a protein divided by the total non-grouping spectral counts for the 8 mass
spectral runs from the gels slices from each lane (http://www.proteomesoftware.com/). The
Quantitative Value allows a relative quantitative comparison between a specific protein from
different samples and relative abundance between proteins for a particular exudate sample.
Immunochemical detection of ECM proteins in wound exudates
For immunoblotting, 100 μg protein of each exudate sample were separated under reducing
conditions on 4–15% Tris–HCl polyacrylamide gradient gels, and transferred to nitrocellulose
membranes. Immunodetection was performed by incubating the membranes overnight at 4°C
stirring with rabbit anti-type IV collagen polyclonal antibody at a dilution of 1:200 (Abcam
ab19808), rabbit anti-nidogen 1 polyclonal antibody at a dilution of 1:500 (Abcam ab14511),
rabbit anti-laminin polyclonal antibody at a dilution of 1:1,000 (Thermo PA1-32130), rabbit
anti-type VI collagen polyclonal antibody at a dilution of 1:2,000 (Millipore AB7821), rabbit
anti-type I collagen polyclonal antibody at a dilution of 1:1,000 (Abcam ab21286), or rabbit
anti-fibronectin polyclonal antibody at a dilution of 1:3,000 (Abcam ab2413). The reaction was
developed using anti-rabbit peroxidase antibody at a dilution of 1:5,000 (Jackson ImmunoRe-
search) and the chemiluminescent substrate Lumi-Light (Roche). Images were captured with
the ChemiDoc XRS+ System (BioRad) and the analysis was performed with the ImageLab soft-
ware (BioRad).
Quantification of proteolytic activity of wound exudates
Gelatinase assay. Proteolytic activity on fluorescent gelatin of wound exudates was
assessed using a commercial kit (EnzCheck protocol Gelatinase/Collagenase Assay Kit, Molec-
ular Probes, Life Technologies) in order to determine whether active SVMPs are present in the
wound exudates. Exudate samples were collected as described above at 1 h, 6 h and 24 h after
intramuscular injection of 100 μg of B. asper venom. A venom dose of 100 μg, instead of 50 μg,
was used in these experiments in order to increase the sensitivity of the assay for detection of
proteinase activity. Exudate samples were pooled, centrifuged at 5,000 g for 3 min and kept at
-70°C until the proteolytic assays were performed. 50 μL of each exudate sample were incu-
bated with 20 μg of gelatin fluorescein conjugate substrate in a total volume of 200 μL, in a 96
well microplate, protected from light, at room temperature, for 24 h. Each sample was tested in
triplicate and a reagent blank was included. Fluorescence intensity was measured in the BioTek
Synergy HT microplate reader setting the absorption filter at 495 nm and the emission filter at
515 nm. In order to determine whether proteolytic activity detected in exudate samples is due
to SVMP or endogenous proteases, neutralization and zymography assays were performed
with the exudate samples.
Neutralization assay. Exudate samples collected at 1 h were incubated with polyclonal
antibodies against the SVMP BaP1 for 20 min at 37°C prior to testing the exudate in the gelati-
nase activity assay described above. The antibody against BaP1 was obtained from the serum of
rabbits immunized with BaP1; antibodies were purified by affinity chromatography. This anti-
body was used since BaP1 is the most abundant SVMP in the venom of adult B. asper snakes
[18]. Previous studies showed that anti-BaP1 antibodies do not react with PIII SVMPs from B.
asper venom and with MMPs [19,20]. Exudate samples collected at 1 h were selected for the
neutralization assay since the highest proteolytic activity on fluorescent gelatin was observed at
this time interval.
Zymography assay. Proteinase activity of exudate samples was visualized by gelatin zymo-
graphy according to the method described by Herron et al. [21] and modified by Rucavado
Proteomic Analysis of Venom-Induced Tissue Damage
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004599 April 1, 2016 5 / 22
et al. [20]. Briefly, 10 μg protein of each exudate sample were separated on 7.5% SDS-polyacryl-
amide gel prepared with 0.50 mg/mL of Type A gelatin (Sigma Chemical Co., St Luis, MO).
After electrophoretic run at 100 V, the gel was washed with 1% Triton X-100 for 30 min under
agitation. Then, the gels were incubated with zymography buffer (50 mM Tris-HCl, 5 mM
CaCl2, 2 g/L NaN3, pH 8.0) for 20 h at 37°C, stained for 2 h with Coomassie Blue R-250, and
destained with water for 20 min.
Results
Pathological observations
The pathological alterations induced by B. asper venom were studied on mouse gastrocnemius
muscle tissue over a time period of 24 h. Tissue sections from control mice injected with PBS
showed normal histological features of skeletal muscle tissue with transverse bundles of muscle
fibers, surrounded by connective tissue and normal vascular and nerve structures (Fig 1A). Tis-
sue sections from mice injected with B. asper venom showed intense hemorrhage at 1 h (Fig
1B) and 6 h (Fig 1C), evidenced by the presence of abundant erythrocytes in the interstitial
space surrounding muscle fibers. After 24 h of injection of B. asper venom, the hemorrhage
decreased since the amounts of extravascular erythrocytes was reduced as compared to previ-
ous time intervals (Fig 1D), consistent with previous observations [7].
Moreover, tissue sections from mice injected with venom revealed prominent necrosis of
skeletal muscle fibers at the first hour interval (Fig 1B and 1C). After 24 h following venom
injection, the bundles of muscle fibers appeared partially lost and disorganized with a hyaline
appearance (Fig 1D). These pathological observations also agree with previous studies
[7,11,12]. Additionally, an infiltration of inflammatory cells was observed in tissue sections,
especially after 6 h and 24 h of venom injection with a marked increment at 24 h (Fig 1D). The
predominant cell type was polymorphonuclear leukocytes, although a proportion of mononu-
clear cells, i.e. macrophages, were also observed at 24 h. These observations also agree with pre-
vious studies [9].
On the other hand, CK activity of exudate samples collected after injection of venom was
228,776 ± 47,137 IU/L at 1 h, 162,344 ± 23,371 IU/L at 6 h, and 23,371 ± 11,660 IU/L at 24 h
(Fig 1E). CK is a marker of plasma membrane damage and cell death of skeletal muscle fibers;
hence it appears that myotoxic activity of the venom is highest at one hour, decreasing after-
wards. These results are in agreement with the muscle tissue damage observed in the histologi-
cal analysis, which occurs early on in the course of envenoming.
Proteomic analysis of wound exudates
Wound exudate samples collected from mice injected with B. asper venom were decomplexed
by SDS-PAGE for subsequent proteomic analysis. From the mass spectrometric analysis of the
gel bands, a total of 537, 578, and 486 proteins were identified in exudates at 1 h, 6 h, and 24 h,
respectively, with protein identification probability above 95% and minimum of two peptides
(S1 Table). The most abundant proteins identified based on their Quantitative Value (see
http://www.proteomesoftware.com/ for full description of term) were classified within the fol-
lowing groups: intracellular proteins (Table 1 and S2 Table), ECM proteins (Table 2), mem-
brane proteins (S3 Table), coagulation factors (S4 Table), and proteinase inhibitors (S5 Table).
Within each group, the proteins were organized by those that changed at least three fold as
compared to another time and proteins which did not show significant change between the
three time intervals, i.e. those whose amounts did not differ more than threefold between
times.
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Fig 1. Histological analysis andmyotoxicity induced by B. asper venom in mouse gastrocnemius muscle.Groups of four mice were injected in the
gastrocnemius with 50 μg of B. asper venom. After 1, 6 and 24 h of injection, mice were sacrificed and samples of exudate and muscle tissues were collected
for quantification of creatine kinase (CK) activity and histological analysis, respectively. Tissue samples were collected at 1 h (B), 6 h (C) and 24 h (D) after
injection and processed for embedding in paraffin. Tissue injected with PBS (A) was used as control. Notice abundant erythrocytes (arrow) at 1 h and 6 h,
and abundant infiltration of inflammatory cells at 24 h (asterisk). Hematoxylin–eosin staining. Bar represents 100 μm. (E) CK activity of exudate was
quantified using a commercial kit (see Methods for details). Results are expressed as mean ± S.D (n = 4).
doi:10.1371/journal.pntd.0004599.g001
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Table 1. More abundant intracellular proteins identified in wound exudates collected frommice at 1, 6 and 24 h after injection ofB. asper venom,
which changed at least three fold at one time as compared to another time.
Protein Accession Number Molecular mass Quantitative Value
1h 6h 24h
Creatine kinase M-type P07310 43 kDa 651 404 96
Fructose-bisphosphate aldolase A6ZI44 45 kDa 357 216 109
Phosphorylase E9PUM3 88 kDa 300 294 47
Carboxylesterase 1C P23953 61 kDa 200 168 0
Alpha-actinin-2 Q9JI91 104 kDa 190 298 59
Alpha-actinin-3 O88990 103 kDa 161 206 55
Actin, alpha skeletal muscle P68134 42 kDa 120 258 220
L-lactate dehydrogenase G5E8N5 40 kDa 105 87 34
Triosephosphate isomerase P17751 32 kDa 98 96 27
Bisphosphoglycerate mutase O70250 29 kDa 93 15 14
Coﬁlin-1 P18760 19 kDa 83 10 92
Peroxiredoxin-5, mitochondrial P99029 [2] 22 kDa 83 16 17
Glutathione peroxidase 1 P11352 22kDa 83 13 14
Isoform 2 of Myc box-dependent-interacting protein 1 O08539-2 [2] 48 kDa 83 22 0
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 Q8R429 [2] 109 kDa 80 77 0
UTP–glucose-1-phosphate uridylyltransferase Q91ZJ5 57 kDa 74 78 11
Myosin-binding protein H P70402 53 kDa 74 67 0
Ubiquitin-40S ribosomal protein S27a P62983 [2] 18 kDa 74 15 26
Flavin reductase (NADPH) Q923D2 22 kDa 74 15 22
L-lactate dehydrogenase B chain P16125 37 kDa 65 18 80
Malate dehydrogenase, mitochondrial P08249 36 kDa 65 63 14
Myosin-9 Q8VDD5 226 kDa 65 10 31
Phosphoglycerate kinase 1 P09411 45 kDa 58 47 15
Heat shock cognate 71 kDa protein P63017 [4] 71 kDa 51 73 17
Aconitate hydratase, mitochondrial Q99KI0 85 kDa 48 99 10
Thioredoxin P10639 12 kDa 46 16 92
Isoform 3 of Elongation factor 1-delta P57776-3 73 kDa 46 78 23
Isoform Cytoplasmic of Fumarate hydratase, mitochondrial P97807-2 50 kDa 46 15 69
Myosin-4 Q5SX39 [9] 223 kDa 43 620 529
Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial Q9D6R2 40 kDa 37 67 0
Glucose-6-phosphate isomerase P06745 63 kDa 31 52 17
Ubiquitin-like protein ISG15 Q64339 18 kDa 28 90 34
3-ketoacyl-CoA thiolase, mitochondrial Q8BWT1 42 kDa 28 90 11
Protein disulﬁde-isomerase P09103 57 kDa 28 17 69
Superoxide dismutase [Cu-Zn] P08228 16 kDa 28 10 57
L-lactate dehydrogenase C chain P00342 36 kDa 26 20 80
Peptidyl-prolyl cis-trans isomerase A P17742 18 kDa 22 67 24
Adenylate kinase isoenzyme 1 Q9R0Y5 [2] 22 kDa 20 78 23
Myosin regulatory light chain 12B Q3THE2 20 kDa 19 34 57
Isocitrate dehydrogenase [NADP], mitochondrial P54071 51 kDa 19 78 0
Coﬁlin-2 P45591 19 kDa 17 78 46
Clathrin heavy chain 1 Q68FD5 192 kDa 17 18 92
Glutathione S-transferase P 1 P19157 24 kDa 16 15 80
Elongation factor 1-gamma Q9D8N0 50 kDa 16 22 69
Carboxypeptidase N catalytic chain Q9JJN5 52 kDa 12 90 92
(Continued)
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A total of 222 intracellular proteins (Table 1 and S2 Table) and 13 membrane proteins (S3
Table) were detected in exudates, thus demonstrating direct or indirect cellular damage
induced by the venom. The most abundant intracellular proteins detected in exudates were
hemoglobin subunit beta-2 and creatine kinase M-type, in agreement with the hemorrhagic
and myotoxic activity of B. asper venom, respectively. Moreover, the creatine kinase M-type
identified in the exudates was detected at the highest level at 1 h, and decreased over time until
Table 1. (Continued)
Protein Accession Number Molecular mass Quantitative Value
1h 6h 24h
GTP-binding nuclear protein Ran, testis-speciﬁc isoform Q61820 [2] 24 kDa 11 34 80
Myosin light chain 1/3, skeletal muscle isoform P05977 [2] 21 kDa 10 26 59
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial Q9CQA3 32 kDa 1 78 92
ATP synthase subunit beta, mitochondrial P56480 56 kDa 1 34 80
Tropomyosin beta chain P58774 33 kDa 1 78 33
doi:10.1371/journal.pntd.0004599.t001
Table 2. Extracellular matrix proteins identified in wound exudates collected frommice at 1, 6 and 24 h after injection ofB. asper venom.
Protein Accession Number Molecular mass Quantitative value
1 h 6 h 24 h
Proteins which changed at least three fold at one time as compared to another time
Basement membrane-speciﬁc heparan sulfate proteoglycan core protein B1B0C7 [2] 469 kDa 83 56 0
Collagen alpha-1(XVIII) chain E9QPX1 [2] 182 kDa 74 22 0
Thrombospondin-1 P35441 130 kDa 65 16 11
Protein Col6a3 E9PWQ3 354 kDa 56 45 0
Collagen alpha-1(XV) chain A2AJY2 [2] 138 kDa 56 45 0
Collagen alpha-2(IV) chain P08122 167 kDa 37 11 0
Collagen alpha-1(IV) chain P02463 161 kDa 19 11 0
Nidogen-2 O88322 154 kDa 19 11 0
Nidogen-1 P10493 137 kDa 19 56 0
Collagen alpha-1(III) chain P08121 139 kDa 12 45 23
Collagen alpha-2(I) chain Q01149 130 kDa 16 22 57
Collagen alpha-1(I) chain P11087 138 kDa 15 13 57
Laminin subunit gamma-1 P02468 [2] 177 kDa 1 56 46
Fibrillin-2 Q61555 314 kDa 1 22 0
Chondroitin sulfate proteoglycan 4 Q8VHY0 252 kDa 0 22 11
Fibrillin-1 A2AQ53 [2] 312 kDa 0 22 0
Collagen alpha-1(XII) chain E9PX70 [3] 334 kDa 0 22 0
Proteins which did not change more than three-fold at any time as compared to another time
Fibronectin P11276 273 kDa 275 194 291
Thrombospondin-4 Q9Z1T2 106 kDa 65 34 46
Vitronectin P29788 55 kDa 19 13 10
Dermatopontin Q9QZZ6 24 kDa 19 11 23
Proteoglycan 4 E9QQ17 [4] 111 kDa 19 11 13
Collagen alpha-1(XIV) chain B7ZNH7 193 kDa 12 16 29
Lumican P51885 38 kDa 11 11 17
doi:10.1371/journal.pntd.0004599.t002
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reaching a six fold reduction at 24 h. These results are in agreement with the CK activity of exu-
dates and the muscle tissue damage observed in the histological analysis. In contrast, there was
a trend for cytoskeletal proteins, such as actin, myosin, and tropomyosin, to increase in the
exudates over time, while most of cytosolic and mitochondrial proteins appeared at the first
hour of venom injection, and decreased afterwards.
Of serum proteins, a total of 10 coagulation factors (S4 Table) and 14 proteinase inhibitors
(S5 Table) were detected in exudates at various times. Fibrinogen beta and gamma chains
appeared in the exudates at the first hour following venom injection and their abundance
increased over time. Other coagulation factors detected whose amounts changed at least three
fold as compared to values at other time were coagulation factor X, XII, and XIII. The inter
alpha-trypsin inhibitor was the only proteinase inhibitor that increased at least threefold at 24
h as compared to 1 h and 6 h.
A total of 24 ECM proteins were identified in exudates, of which 21, 24, and 13 proteins
were detected at 1 h, 6 h, and 24 h, respectively (Table 2). Most of these proteins showed a dif-
ferential abundance greater than three-fold between samples collected at different times. The
most abundant basement membrane (BM) protein detected in the wound exudates was BM-
specific heparan sulfate proteoglycan core protein (perlecan), followed by alpha 1 and 2
chains of type IV collagen. Most of the BM components, such as heparan sulfate proteogly-
can, type IV collagen and nidogen-2, appeared in the exudates at 1 h, and the amount
decreased over time, largely becoming undetectable at 24 h. Conversely, the amount of lami-
nin γ-1 detected in the exudates increased at 6 h and 24 h, and the amount of nidogen-1
increased at 6 h as compared to 1 h and 24 h (Fig 2A). Other collagens, such as types VI, XV,
and XVIII collagens, were present in the exudates at 1 h and 6 h, but were not detected at 24
h. Interestingly, type I collagen was also detected in the exudates at the first hour and its
abundance increased at 24 h (Fig 2B). Other ECM proteins detected in the exudates whose
abundance were greater at 6 h as compared to 1 h and 24 h were type III collagen, fibrillin 1
and 2, chondroitin sulfate proteoglycan 4, and type XII collagen. On the other hand, throm-
bospondin 1 appeared in the exudates at 1 h and decreased over time. Other ECM proteins
detected in the exudates whose amounts did not vary more than threefold between times
were fibronectin, thrombospondin-4, vitronectin, dermatopontin, proteoglycan 4, type XIV
collagen, and lumican (Table 2).
Immunochemical detection of ECM proteins in wound exudates
Type IV collagen. Immunodetection of type IV collagen in wound exudates showed one
prominent band of 107 kDa, with additional faint bands of 217 kDa, 172 kDa, 135 kDa and 70
kDa at 1 h and 6 h (Fig 3A). A reduction of intensity of the 107 kDa band was observed at 6 h
as compared to 1 h. The molecular mass of the prominent band does not agree with the molec-
ular mass of the alpha chains of type IV collagen (145–160 kDa). Thus, these bands very likely
constitute degradation products. Type IV collagen and its degradation products were not
detected in exudate samples collected at 24 h. Therefore, according to Western blot results,
there is a rapid degradation of type IV collagen within the first 6 hours.
Laminin. Immunodetection of laminin showed the presence of this protein in the wound
exudates at 1, 6, and 24 h with two prominent bands of 220 kDa and 140 kDa (Fig 3B). These
bands agree with the molecular mass of some isoforms of alpha, beta, and gamma chains (130–
200 kDa) of this protein. A reduction of intensity of the 220 kDa band was observed at 1 h as
compared to 6 h and 24 h. The band of 140 kDa was not detected at 1 h. A reduction of inten-
sity of the 220 kDa band and an increase of the intensity of the 140 kDa band were observed at
24 h as compared to 6 h.
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Nidogen 1. Western blot analysis of wound exudates for nidogen 1 showed two prominent
bands of 120 and 40 kDa (Fig 3C), which are likely to be degradation fragments. A reduction of
the 40 kDa band with an increase of the 120 kDa band was observed over time.
Type I collagen. Immunodetection of type I collagen showed three bands corresponding
to proteins of 135 kDa, 120 kDa and 107 kDa at 1 h and 6 h (Fig 3D). An increase in the inten-
sity of these bands, in particular the 120 kDa, was observed at 6 h as compared to 1 h. These
bands agree with the molecular mass of some isoforms of alpha 1 (120 kDa) and alpha 2 (115
kDa) chains. Collagen I and degradation products were not detected at 24 h in the exudates.
Fig 2. Extracellular matrix proteins identified in wound exudates collected frommice after injection of B. asper venom.Groups of five mice were
injected in the gastrocnemius with 50 μg of B. asper venom. After 1, 6 and 24 h of injection, mice were sacrificed and samples of exudate were collected,
pooled and lyophilized. Proteomic analysis of exudates was performed as described in Methods. Proteins from the BM are included in (A), whereas other
ECM proteins are depicted in (B). Only proteins whose amount varied at least three fold between time intervals were included in this figure. Notice that the
level of BM proteins and non-fibrillar collagens are higher at 1 h, whereas type I collagen levels are higher at 24 h.
doi:10.1371/journal.pntd.0004599.g002
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Overall there is a trend of increasing abundance of type I collagen in the exudates by Western
blot analyses at 6 h as compared to 1 h.
Type VI collagen. Immunoblotting of wound exudates for type VI collagen showed one
prominent band of 230 kDa, and a faint band of 118 kDa at 1 h and 6 h (Fig 3E). The presence
of a band of 118 kDa in the first 6 h indicates degradation of type VI collagen early in the
course of envenoming. A reduction of the 118 kDa band, with an increase of the 230 kDa band,
was observed over time. Therefore, according to Western blot results, type VI collagen is
degraded in the first hours, and then type VI collagen increases and appears in the exudates
collected at 24 h.
Fibronectin. Immunodetection of fibronectin showed two bands of 265 kDa and 236 kDa,
with additional faint bands of 175 kDa, 140 kDa, and 100 kDa at 1 h, 6 h and 24 h (Fig 3F). An
increase of intensity of the most abundant bands and a reduction of the faint bands were
observed at 24 h as compared to 1 h and 6 h. The molecular mass of the 265 kDa band agrees
Fig 3. Western blot analysis of extracellular matrix components in wound exudates collected frommice after injection ofB. asper venom.Groups
of five mice were injected in the gastrocnemius with 50 μg of B. asper venom. After 1, 6 and 24 h of injection mice were sacrificed and samples of exudates
were collected, pooled and lyophilized. Afterwards, 100 μg of protein of each sample were separated under reducing conditions on 4–15% Tris–HCl
SDS-PAGE, and transferred to nitrocellulose membranes. Immunodetection was performed with (A) anti-type IV collagen (Col IV), (B) anti-laminin, (C) anti-
nidogen 1, (D) anti-type I collagen (Col I), (E) anti-type VI collagen (Col VI), and (F) anti-fibronectin. The reaction was detected using an anti-rabbit peroxidase
antibody and a chemiluminescent substrate. Images were obtained with the ChemiDoc XRS+ System (BioRad).
doi:10.1371/journal.pntd.0004599.g003
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with the molecular mass expected (262 kDa). Therefore, according to Western blot results,
fibronectin is degraded in the first hours, but it remains present at 24 h in the exudates.
Proteolytic activity of wound exudates
In order to determinate whether SVMP or endogenous proteases are active in the wound exu-
dates, proteolytic activity assays of exudate samples were performed. Exudate samples collected
from mice injected with B. asper venom at 1 h showed the highest proteolytic activity on gelatin
fluorescein conjugate compared with samples collected at 6 h and 24 h. (Fig 4A). When exu-
dates collected at 1 h were incubated with polyclonal antibody against the SVMP BaP1, the
proteolytic activity of the exudates was almost completely inhibited since only 8% of the activ-
ity remained.
Using zymography several gelatinolytic bands were detected corresponding to proteins of
50–150 kDa in the exudate samples collected at different times (Fig 4B). An increase of two
main bands of about 100 kDa and 60 kDa was observed in exudates collected at 6 h and 24 h.
These molecular masses are consistent with the latent forms of matrix metalloproteinases
(MMP) 9 and 2, respectively [22]. Therefore, the zymography showed an increase of proteo-
lytic activity of endogenous MMPs in exudate over time. Furthermore, bands corresponding to
the molecular mass of the SVMP BaP1 were not detected in the zymographic analysis of exu-
date samples.
Discussion
Envenoming by venomous snakes gives rise to a complex pathophysiology by virtue of the com-
plexity of the venoms and the fact that the toxins in the venom produce manifold effects in the
tissues. Proteomic analysis of wound exudates collected in the vicinity of affected tissue consti-
tutes a powerful approach to study the pathogenesis of tissue damage induced by snake venoms
from a more comprehensive perspective [13–17], thus complementing histological,
Fig 4. Proteolytic activity of wound exudates collected frommice after injection ofB. asper venom.Groups of five mice were injected in the
gastrocnemius with 100 μg of B. asper venom. After 1, 6 and 24 h, mice were sacrificed and samples of exudates were collected. (A) Proteolytic activity of
exudate samples was measured after 24 h of incubation with gelatin fluorescein conjugate using a commercial kit (EnzCheck protocol Gelatinase/
Collagenase Assay Kit, Molecular Probes, Life Technologies) as described in Methods. Results are expressed as mean ± S.D (n = 3) of Fluorescence
Arbitrary Units (A.U.). (B) Exudate samples were separated in a 7.5% SDS-polyacrylamide gel containing 0.50 mg/mL of Type A gelatin. The gel was
incubated at 37°C and then stained with Coomassie blue R-250. MMP: matrix metalloproteinase (see text for explanation); M: lane corresponding to
molecular mass markers.
doi:10.1371/journal.pntd.0004599.g004
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ultrastructural and biochemical analyses. This methodological tool has been used to investigate
the early alterations provoked by B. asper venom [15] and some of its toxins, especially myotoxic
PLA2s and hemorrhagic SVMPs [13,14,16], as well as the inhibitory effects of antivenoms and
low molecular mass inhibitors [15]. However, analyses in these previous studies were performed
at a single time interval after injection, thus precluding the understanding of these events from a
time-course perspective. In this study, we investigated the dynamics of local effects induced by
B. asper venom in the gastrocnemius muscle of mice at various time intervals.
Our histological and biochemical observations agree with previous studies showing a rapid
development of myonecrosis and hemorrhage, followed by an inflammatory process character-
ized by the infiltration of neutrophils and macrophages at later time intervals [4,5,7,9,10]. Pre-
vious works on venom-induced myonecrosis have quantified CK activity in plasma [6], where
the highest levels were observed at 3 h post envenoming. In contrast, in exudates, highest CK
levels are higher than in plasma, and peak activity occurs at 1 h instead of 3 h. This difference
may be attributed to the kinetics of absorption of this enzyme into the circulation after its
release from damaged muscle fibers, since exudate was collected close to the venom-injected
muscle. In agreement with previous pathological and proteomic studies, intracellular proteins
were abundant in exudates, as a consequence of the cytotoxic effect of venom, especially on
skeletal muscle fibers [7,11,14,15]. The time-course analysis of the intracellular proteins in exu-
date underscores that most of the cytosolic and mitochondrial proteins appear early on due to
the rapid action of myotoxic PLA2s and PLA2 homologues in muscle tissue [7,11,14,15,23], fol-
lowed by a decrease of these proteins. Most of these proteins are derived from the cytosol of
skeletal muscle fibers since myotoxic PLA2s induce a rapid disruption of the integrity of muscle
cell plasma membrane [4,7,24]. The high CK activity of exudates at 1 h and our histological
observations corroborate the early onset of myonecrosis in the course of envenoming and
agree with proteomic analysis.
In contrast to cytosolic proteins, most of the cytoskeletal proteins, such as actin, myosin,
and tropomyosin, are more abundant in exudates collected at later time periods. This late
increment suggests that the presence of cytoskeletal protein fragments in the exudate depends
on the action of proteinases that release these structural components from damaged cells. A
prominent calcium influx in muscle cells occurs after venom-induced plasma membrane dam-
age [25,26]. An increased calcium concentration in the cytosol results in the activation of cal-
pains, which might hydrolyze cytoskeletal components [27]. Subsequently, proteinases derived
from inflammatory cells arriving at the necrotic tissue may also contribute to proteolysis of
muscle cytoskeletal proteins [9,10]. Thus, the proteomic analyses reveals two ‘waves’ of release
of intracellular proteins to exudates: an early release of cytosolic and mitochondrial proteins,
which depends on the rapid myotoxin-induced membrane damage, and a more delayed release
of cytoskeletal protein fragments, which is due to proteolytic degradation.
The presence of cell membrane-associated proteins may be evidence of direct or indirect cel-
lular damage induced by the venom. Moreover, proteolysis of these components, either by
venom or endogenous proteinases, may cause their ‘shedding’ and diffusion to the exudate
compartment. It is tempting to speculate that, in addition to being a passive reflection of
venom-induced plasma membrane damage, the release of these protein fragments may also
play a functional role in cellular signaling associated with inflammatory and reparative events.
However, the pathological relevance of the hydrolysis of these proteins in the overall mecha-
nism of local tissue damage induced by snake venoms has not been established and needs fur-
ther study.
The presence of ECM proteins in wound exudates reflects the cleavage by either venom-
derived proteinases or endogenous proteinases, such as MMPs, generated in the course of the
inflammatory response. The degradation of ECM is a relevant component of viperid venom-
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induced tissue damage, and proteomic analysis has been particularly useful in revealing a com-
plex pattern of hydrolysis [14–16]. Previous studies detected B. asper venom components in
muscle homogenates of mice during the first week after experimental envenoming [28]; how-
ever, the activity of these toxins has not been previously addressed. When assessing the pro-
teinase activity of exudates, highest activity was detected in samples collected after 1 h of
envenoming; here we demonstrate that this is mainly due to the action of SVMPs, since anti-
bodies against BaP1, the most abundant proteinase in B. asper venom [29], almost fully inhib-
ited exudate-induced proteolysis. However, this enzymatic activity decreased over time,
probably as a consequence of diffusion of venom components from the injected muscle or of
inhibition by plasma or tissue-derived proteinase inhibitors. It is likely that activity at later
time intervals, i.e. 24 h, is mostly due to endogenous MMPs generated in the course of the
inflammatory response, such as MMP-9 and MMP-2, which was confirmed by the detection
with zymography of the wound exudates, although it remains possible that some venom pro-
teinases persisting in the tissue may also contribute to this observation. These results agree
with previous studies which demonstrated an increase in the expression of MMP-9 and MMP-
2 in muscle tissue injected with B. asper venom [28] or with purified SVMP and PLA2 toxins
[30]. Taken together these findings suggest that the hydrolysis of ECM is mainly due to SVMPs
in the early stages of envenoming, while endogenous MMPs participate later in the course of
envenoming.
A large body of experimental evidence indicates that BM and related ECM components that
provide stability to microvessel structure are the key targets of hemorrhagic SVMP
[5,13,14,16,31–34]. Moreover, SVMP-induced hemorrhage occurs very fast after injection
[12,35–37]. Therefore, the presence of ECM components in wound exudates during first hour
as compared to later time periods may offer important insights for understanding the mecha-
nism of action of hemorrhagic SVMPs. Regarding BM components, the presence of degrada-
tion products of perlecan, type IV collagen, nidogen, and laminin in wound exudates
underscores a rapid and drastic damage of BM structure. In particular, perlecan and type IV
collagen are abundant in exudates after the first hour, when hemorrhagic events have occurred,
and then their amounts decrease over time, as they were not detected by proteomic analysis at
24 h. Western blot analysis of exudate confirmed the presence of fragments of type IV collagen
1 h after venom injection.
Perlecan is the most abundant BM protein detected in the wound exudates during the first
hour. In previous proteomic studies, we have found that the relative amount of perlecan in
wound exudates induced by a hemorrhagic SVMP was greater as compared to a non-hemor-
rhagic one [13], but similar when compared to other hemorrhagic SVMPs [16], and its pres-
ence was abolished when B. asper venom was previously incubated with batimastat [15], a
metalloproteinase inhibitor. Such findings, together with our data, suggest that degradation of
perlecan in early stages of envenoming may play an important role in the hemorrhagic mecha-
nism of SVMPs. This proposal agrees with the known structural role of perlecan in BM [38–
42]. In addition, mutations in the perlecan gene in mice have been associated with loss of BM
integrity in different tissues [43–45], including microvasculature of brain and skin, which
cause severe bleedings due to dilatation and rupture of microvessels [45].
On the other hand, previous proteomic studies using similar models have not detected
type IV collagen in wound exudates induced by B. asper venom or its toxins [13–16]. How-
ever, several studies using in vitro and in vivomodels have identified type IV collagen as one
of the most likely key components degraded by hemorrhagic SVMPs and associated with the
initial microvessel destabilization and hemorrhage [5,13,16,34,46,47]. Our present proteomic
results did identify fragments of type IV collagen in exudates at 1 h, thus agreeing with previ-
ous immunohistochemical and immunochemical evidence [13,16]. In addition, according to
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Western blot analysis, degradation products of type IV collagen appear in exudates in sam-
ples collected at 1 h. Such early appearance of type IV collagen and perlecan strongly suggest
that their degradation is due to the direct proteolytic activity of SVMPs. The hypothesis that
type IV collagen is a key target in the hemorrhagic mechanism of SVMPs is compatible with
the structural role of this collagen in the mechanical stability of BM, as it is stabilized by cova-
lent cross-links [41,42,48–51]. In addition, mutations on type IV collagen genes have been
associated with pathological alterations in microvessels and with hemorrhage in brain, kid-
ney and lungs in mice and humans [52–58]. Thus, the rapid hydrolysis of perlecan and type
IV collagen after injection of B. asper venom supports the view that BM destabilization lead-
ing to hemorrhage is likely to depend on the degradation of these mechanically-relevant
components.
Nidogen 2 appeared in early time periods in wound exudates, in agreement with previous
proteomic studies [13,15], and then it decreased over time in our proteomics analysis. Since
nidogen 2 is more abundant in the BM of blood vessels [59], and its time-course dynamics of
appearance in exudates is similar to that observed for type IV collagen and perlecan, the release
of nidogen 2 might be associated with vascular BM damage. In contrast, taken together the
proteomic and Western blot analyses showed that nidogen 1 increased over time in wound
exudates. In addition, nidogen 1 and 2 have been detected in plasma of healthy mice [60],
which could explain the presence of nidogen 1 in the wound exudates according to Western
blot results. On the other hand, laminin γ1, which is widely distributed [61,62], also increased
over time in wound exudates. The time-course variation of the molecular masses of immunore-
active bands in the cases of nidogen 1 and laminin underscores the dynamics of degradation of
these components over time. Furthermore, Escalante et al. [13] demonstrated similar patterns
of degradation for nidogen and laminin in muscle tissue induced by hemorrhagic and non-
hemorrhagic SVMPs.
Our observations allowed the analysis of the time-course dynamics of the hydrolysis of non-
fibrillar collagens associated with the BM, such as types VI, XV, and XVIII collagens. As in the
case of type IV collagen and perlecan, hydrolysis of these components was highest at 1 h, hence
indicating a rapid degradation, probably by venom proteinases. These collagens connect the
BM with fibrillar collagens of the matrix [39,63], and are known to play a relevant role in the
mechanical stability and integration of BM with connective tissue [39,63]. Hence, the hydroly-
sis of these components by SVMP might be also critical for capillary wall destabilization, as
have been previously proposed [13,64]. Alternatively, the increase of these collagens in exu-
dates might be consequence of BM damage after the hydrolysis of other components, such as
type IV collagen and perlecan. Type VI collagen is more abundant in the BM of muscle cells
[65–67]; thus the increment of non-degraded type VI collagen chains in exudates could reflect
synthesis de novo during reparative and regenerative events in muscle tissue. The role of the
degradation of these collagens in the initial destabilization of BM induced by hemorrhagic
SVMP is an issue that should be further investigated.
Other ECM components of interest detected in the proteomic analysis are collagen I and
fibronectin. Collagen I is a fibril-forming collagen distributed in non-cartilaginous connective
tissues such as skin and connective tissue of muscle [63]. According to proteomic results, the
relative abundance of collagen I in exudates is higher at 24 h as compared to 1 and 6 h. This
late hydrolysis of collagen I could be result of the action of endogenous MMPs synthesized dur-
ing the course of inflammation in the damage tissue. Fibronectin was detected in the exudates
both in proteomic and immunochemical analyses. This protein can be found in two forms:
plasma fibronectin, which is a soluble molecule synthesized by hepatocytes, and cellular fibro-
nectin, which is produced in the tissues and is incorporated in the ECM [62]. Thus, the pres-
ence of fibronectin in exudates could be either a consequence of plasma exudation or
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hydrolysis from the ECM. According to proteomic analysis, the amount of fibronectin in exu-
dates does not change over time; however, on the basis of Western blot analysis, it appears to
be more degraded at early time periods most likely due to the action of SVMPs.
Taken together, our observations highlight a dual pattern of ECM protein degradation and
appearance in exudates. Types IV and VI collagens, perlecan, nidogen and fibronectin show a
higher degradation early on in the course of envenoming, correlating with the rapid action of
SVMPs upon venom injection, as demonstrated by the proteinase activity of exudates. The
rapid action of SVMPs on various key components of the BM is likely to be causally related to
microvessel damage and hemorrhage. In the case of the fibrillar collagen I, it seems to be
degraded predominantly by endogenous MMPs at later time periods, during the inflammatory
reaction that ensues in the tissue as a consequence of venom-induced damage, as evidenced by
zymography.
The presence of abundant plasma proteins in the exudate, as revealed by proteomic analysis,
is a consequence of plasma exudation as a result of edema and increment in vascular perme-
ability induced by the venom [68,69]. Some of the plasma proteins detected are acute-phase
proteins, proteinase inhibitors and coagulation factors. Of interest is the increase of fibrinogen
and the inter α-trypsin inhibitor heavy chains over time.
The presence of fibrinogen in exudates might be secondary to the inflammatory exudation
induced by the venom since this protein is typically found in plasma at high concentrations
[70]. Previous proteomic studies have found fibrinogen in the wound exudates induced by B.
asper venom and its toxins, especially SVMP BaP1, early in the course of envenoming [14,15].
Our data show an increase of fibrinogen in wound exudates over time. This increment might
be consequence of fibrin clot formation in capillary walls, due to vascular damage induced by
SVMPs [12,14,35], and also to fibrin formation in the extravascular interstitial space, followed
by fibrinolysis by endogenous proteinases [70], thus explaining their higher amounts in exu-
dates collected at later time intervals.
The inter-α-trypsin inhibitor heavy chains are mainly secreted into the blood by the liver as
serum protease inhibitor whose concentration increases in inflammatory conditions [71]. The
effect of these proteins in tissues has been associated with both inflammatory and anti-inflam-
matory activities [71–73]. Moreover, these proteins can be covalently linked to hyaluronan,
exerting functions on cell migration and ECM remodeling under physiological and pathologi-
cal conditions [74,75]. Thus, the increase of inter-α-trypsin inhibitor heavy chains detected in
exudates might be due to an acute-phase inflammatory response and to the tissue inflamma-
tion as a consequence of venom-induced damage.
In conclusion, the proteomic analysis of wound exudates performed in this study provides a
more complete understanding of the time-course dynamics of muscle tissue damage induced
by B. asper venom. These observations, together with Western blot and histology data, provide
a more integrated view of venom-induced local tissue damage (Fig 5). The early presence of
cytosolic and mitochondrial proteins in exudates, as compared to the later increase of cytoskel-
etal proteins, confirms the rapid cytotoxic effect of venom, followed by the action of endoge-
nous proteinases in the cytoskeleton of damaged muscle fibers. On the other hand, the early
presence of BM and other BM-associated ECM components in exudates, together with venom-
derived proteolytic activity of exudates, strongly suggest the hydrolysis of these components by
SVMPs in the early stages of envenoming. In contrast, the increment of some ECM proteins in
the exudates at later time intervals is likely to be due to the action of endogenous MMPs or to
their synthesis de novo during tissue remodeling associated with inflammation and reparative
processes. Finally, the time-course of appearance in wound exudates of type IV collagen and
perlecan supports the role of the hydrolysis of these BM components in the mechanism of
microvascular damage induced by hemorrhagic SVMP.
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Fig 5. Early and late pathological events induced by the venom ofBothrops asper in muscle tissue. (A) The venom of B. asper induces a rapid
cytotoxic (especially myotoxic) and hemorrhagic effects evidenced by the early release of cytosolic and mitochondrial proteins, and the degradation of BM
and related ECM, respectively. (B) Then, MMPs and other endogenous proteinases are associated with tissue remodeling and degradation of cytoskeletal
proteins, especially in skeletal muscle, as part of the inflammatory reaction later on in the course of envenoming. BM: basement membrane; EC: endothelial
cells; ECM: extracellular matrix; SVMPs: snake venommetalloproteinases; SV PLA2s: snake venom phospholipases A2; EP: endogenous proteases.
doi:10.1371/journal.pntd.0004599.g005
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